Advertisement

Pharmaceutisch weekblad

, Volume 3, Issue 1, pp 1181–1187 | Cite as

Receptorinteracties in vivo en in vitro

De toetsing van een hypothese en het werkingsmechanisme van halopemide
  • A. J. M. Loonen
Oorspronkelijke Artikelen

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  1. Biegon, A., enD. Samuel (1979)Biochem. Pharmacol. 28, 3361–3366.CrossRefPubMedGoogle Scholar
  2. Bosmann, H.B., K.R. Case enP. Distefano (1977)FEBS Letters 82, 368–372.CrossRefPubMedGoogle Scholar
  3. Braestrup, C., enR.F. Squires (1977)Proc. Natl. Acad. Sci. USA 74, 3805–3809;Ibidem (1978)Eur. J. Pharmacol. 48, 263–270.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Burt, D.R., I. Creese enS.H. Snyder (1976)Mol. Pharmacol. 12, 800–812.PubMedGoogle Scholar
  5. Christensen, A.V., J. Arnt enJ. Scheel-Krüger (1979)Life Sci. 24, 1395–1402.CrossRefPubMedGoogle Scholar
  6. Costa, E. (1979)Trends Pharmacol. Sci. 1, 41–44.CrossRefGoogle Scholar
  7. Creese, I., R. Schneider enS.H. Snyder (1977)Eur. J. Pharmacol. 46, 377–381.CrossRefPubMedGoogle Scholar
  8. Denef, C., enJ.-J. Follebouckt (1978)Life Sci. 23, 431–436.CrossRefPubMedGoogle Scholar
  9. Enna, S.J., J.P. Bennett Jr, D.R. Burt, I. Creese enS.H. Snyder (1976)Nature (Lond.) 263, 338–341.CrossRefGoogle Scholar
  10. Finch, L. (1975)Eur. J. Pharmacol. 33, 409–412.CrossRefPubMedGoogle Scholar
  11. Fjalland, B. (1978)Acta Pharmacol. Toxicol. 42, 73–76.CrossRefGoogle Scholar
  12. Frederickson, R.C.A. (1977)Life Sci. 21, 23–42.CrossRefPubMedGoogle Scholar
  13. Guidotti, A., M. Baraldi, J.P. Schwartz enE. Costa (1979)Pharmac. Biochem. Behav. 10, 803–807.CrossRefGoogle Scholar
  14. Hyttel, J. (1978)Life Sci. 23, 551–556.CrossRefPubMedGoogle Scholar
  15. Laduron, P., P.F.M. Janssen enJ.E. Leysen (1978)Biochem. Pharmacol. 27, 317–321.CrossRefPubMedGoogle Scholar
  16. Leysen, J.E., W. Gommeren enP.M. Laduron (1978)Biochem. Pharmacol. 27, 307–316.CrossRefPubMedGoogle Scholar
  17. Lloyd, K.G., enS. Dreksler (1979)Brain Res. 163, 77–87.CrossRefPubMedGoogle Scholar
  18. Loonen, A.J.M., enW. Soudijn (1979)Arch. Int. Pharmacodyn. Therap. 237, 267–274;Ibidem (1980)247, 43–58.Google Scholar
  19. Loonen, A.J.M., W. Soudijn, H.H. Van Rooy enI. Van Wijngaarden (1977)Eur. J. Pharmacol. 45, 281–285;Ibidem (1979a)Naunyn-Schmiedebergs Arch. Pharmacol. 309, 281–285.CrossRefPubMedGoogle Scholar
  20. Loonen, A.J.M., I. Van Wijngaarden, P.A.J. Janssen enW. Soudijn (1978)Eur. J. Pharmacol. 50, 403–408;Ibidem (1979b)Life Sci. 24, 609–614.CrossRefPubMedGoogle Scholar
  21. Loonen, A.J.M., C.J. Soe-Agnie enW. Soudijn (1981a)Brain Res. 210, 485–492;Ibidem (1981b) Niet gepubliceerde bevindingen.CrossRefPubMedGoogle Scholar
  22. Mackerer, C.R., R.L. Kochman, B.A. Bierschenk enS.S. Bremner (1978)J. Pharmacol. Exptl. Therap. 206, 405–413.Google Scholar
  23. Melville, E.M., M.J. Turnbull enH. Wheeler (1979)Brit. J. Pharmacol. 66, 123P-124P.Google Scholar
  24. Möhler, H., enT. Okada (1977)Science 198, 849–851.CrossRefPubMedGoogle Scholar
  25. Müller, W.E., U. Schläfer enU. Wollert (1978)Naunyn-Schmiedebergs Arch. Pharmacol. 305, 23–26.CrossRefPubMedGoogle Scholar
  26. Naylor, R.J., enJ.E. Olley (1969)Brit. J. Pharmacol. 36, 208P-209P.Google Scholar
  27. Niemegeers, C.J.E., A. Wauquier enF.M. Lenaerts (1975) Janssen Preclin. Res. Rep. no. R 34301/2.Google Scholar
  28. Raisman, R., M. Briley enS.Z. Langer (1979)Eur. J. Pharmacol. 54, 307–308.CrossRefPubMedGoogle Scholar
  29. Rombaut, N., H. Depoorter enJ. Brugmans (1978)Halopemide, a new potent non-neuroleptic dopamineblocker with psychotropic properties. Commun. at the XIthCinp Congress, Wenen (Oostenrijk), 9–16 juli.Google Scholar
  30. Seeman, P., M. Chau-Wong, J. Tedesco enK. Wong (1975)Proc. Natl. Acad. Sci. USA 72, 4376–4380.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Seeman, P., T. Lee, M. Chau-Wong, J. Tedesco enK. Wong (1976)Proc. Natl. Acad. Sci. USA 73, 4354–4358.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Soudijn, W. (1969)Over Neuroleptica. Metabolisme en localisatie (hersenen) van haloperidol en pimozide. Proefschrift, Leiden.Google Scholar
  33. Wellens, D., A. De Wilde, A. Van Bogaert, P.P. Van Bogaert, L. Wouters, R.S. Reneman enP.A.J. Janssen (1975a)Arch. Int. Pharmacodyn. 215, 91–103.PubMedGoogle Scholar
  34. Wellens, D., L. Snoeckx, R. De Reese, R. Kruger, A. Van De Water, L. Wouters enR.S. Reneman (1975b)Arch. Int. Pharmacodyn. 215, 119–132.PubMedGoogle Scholar
  35. Wellens, D., J.M. Van Nueten enP.A.J. Janssen (1975c)Arch. Int. Pharmacodyn. 213, 334–337.PubMedGoogle Scholar
  36. Worms, P., enK.G. Lloyd (1978)Life Sci. 23, 475–478.CrossRefPubMedGoogle Scholar
  37. Zwieten, P.A. Van (1975)Arch. Int. Pharmacodyn. 215, 104–118.PubMedGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

  • A. J. M. Loonen
    • 1
  1. 1.Laboratorium voor FarmacieVakgroep Farmaceutische ScheikundeTV Amsterdam

Personalised recommendations